Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting

被引：1

作者：

Fougerousse, A. -C. ^{[1
]}

Maccari, F. ^{[2
]}

Beauchet, A. ^{[3
,4
]}

Parier, J. ^{[2
]}

Boulard, C. ^{[5
]}

Becherel, P. -A. ^{[6
]}

Quiles-Tsimaratos, N. ^{[7
]}

Le Guyadec, T. ^{[8
]}

Thomas-Beaulieu, D. ^{[9
]}

Halioua, B. ^{[10
]}

Begon, E. ^{[11
]}

Bastien, M. ^{[12
]}

Perrot, J. -L. ^{[13
]}

Pallure, V. ^{[14
]}

Bilan, P. ^{[15
]}

Steff, M. ^{[15
]}

Pfister, P. ^{[10
]}

Vermersch-Langlin, A. ^{[16
]}

Boye, T. ^{[17
]}

Mery-Bossard, L. ^{[18
]}

Maillard, H. ^{[19
]}

Kemula, M. ^{[10
]}

Girard, C. ^{[20
]}

Poiraud, C. ^{[21
]}

Monfort, J. -B. ^{[22
]}

Kupfer-Bessaguet, I. ^{[23
]}

Perrussel, M. ^{[24
]}

Lons-Danic, D. ^{[25
]}

Sultan, N. ^{[26
]}

Lorier, E. ^{[10
]}

Zeitoun, M. ^{[27
]}

Wagner, L. ^{[10
]}

Gabison, G. ^{[28
]}

Mahe, E. ^{[29
]}

机构：

[1] Hop Instruct Armees Begin, Dept Dermatol, St Mande, France

[2] Private Off, La Varenne St Hilaire, France

[3] Univ Paris Saclay, CHU Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne, France

[4] Univ Paris Saclay, UVSQ, Boulogne, France

[5] Hop Havre, Dept Dermatol, Montivilliers, France

[6] Hop Prive Antony, Dept Dermatol, Antony, France

[7] Hop St Joseph, Dept Dermatol, Marseille, France

[8] Hop Instruct Armees Percy, Dept Dermatol, Clamart, France

[9] Ctr Hosp Intercommunal Poissy St Germain Laye, Dept Dermatol, Poissy, France

[10] Private Off, Paris, France

[11] Hop Rene Dubos, Dept Dermatol, Pontoise, France

[12] Private Off, Joinville Le Pont, France

[13] CHU St Etienne, Dept Dermatol, St Etienne, France

[14] Ctr Hosp, Dept Dermatol, Perpignan, France

[15] Ctr Hosp Robert Ballanger, Dept Dermatol, Aulnay Sous Bois, France

[16] Ctr Hosp, Dept Dermatol, Valenciennes, France

[17] Hop Instruct Armees St Anne, Dept Dermatol, Toulon, France

[18] Ctr Hosp Francois Quesnay, Dept Dermatol, Mantes La Jolie, France

[19] Ctr Hosp, Dept Dermatol, Le Mans, France

[20] CHU St Eloi, Dept Dermatol, Montpellier, France

[21] Ctr Hosp, Dept Dermatol, La Roche Sur Yon, France

[22] CHU Tenon, Dept Dermatol, Paris, France

[23] Ctr Hosp, Dept Dermatol, Niort, France

[24] Private Off, Auray, France

[25] Hop St Joseph, Dept Dermatol, Paris, France

[26] Ctr Hosp Gabriel Martin, Dept Dermatol, St Paul, France

[27] Private Off, Antony, France

[28] Private Off, St Maurice, France

[29] Hop Victor Dupouy, Dept Dermatol, Argenteuil, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 12期

关键词：

EXPERIENCE; SURVIVAL;

D O I：

10.1111/jdv.15804

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E476 / E478

页数：3

共 10 条

[1] Armstrong A, 2017, J DRUGS DERMATOL, V16, P1240
[2] Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients
Cabello Zurita, Camila
Grau Perez, Merce
Hernandez Fernandez, Carlos Pelayo
Gonzalez Quesada, Alicia
Valeron Almazan, Pedro
Vilar Alejo, Jaime
Carretero Hernandez, Gregorio
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (05) : 401 - 405
[3] Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis
Davila-Seijo, P.
Dauden, E.
Carretero, G.
Ferrandiz, C.
Vanaclocha, F.
Gomez-Garcia, F. -J.
Herrera-Ceballos, E.
De la Cueva-Dobao, P.
Belinchon, I.
Sanchez-Carazo, J. -L.
Alsina, M.
Lopez-Estebaranz, J. -L.
Ferran, M.
Torrado, R.
Carrascosa, J. -M.
Llamas, M.
Rivera, R.
Jimenez-Puya, R.
Garcia-Doval, I.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : 1942 - 1950
[4] A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective study
Ighani, Arvin
Georgakopoulos, Jorge R.
Walsh, Scott
Shear, Neil H.
Yeung, Jensen
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : 623 - 626
[5] Treating moderate plaque psoriasis: prospective 6-month chart review of patients treated with apremilast
Knuckles, Melissa L. F.
Levi, Eugenia
Soung, Jennifer
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (05) : 430 - 434
[6] Real-World Experience With Apremilast in Treating Psoriasis
Mayba, Julia N.
Gooderham, Melinda J.
[J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2017, 21 (02) : 145 - 151
[7] Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis
Papadavid, E.
Rompoti, N.
Theodoropoulos, K.
Kokkalis, G.
Rigopoulos, D.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : 1173 - 1179
[8] Factors Associated with Drug Survival of Methotrexate and Acitretin in Patients with Psoriasis
Shalom, Guy
Zisman, Devy
Harman-Boehm, Ilana
Biterman, Haim
Greenberg-Dotan, Sari
Polishchuk, Ilya
Moser, Hadas
Freud, Tamar
Feldhamer, Ilan
Cohen, Arnon D.
[J]. ACTA DERMATO-VENEREOLOGICA, 2015, 95 (08) : 973 - 977
[9] Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France
Tournier, A.
Khemis, A.
Maccari, F.
Reguiai, Z.
Begon, E.
Fougerousse, A-C
de la Breteque, M. Amy
Beneton, N.
Parier, J.
Boye, T.
Avenel-Audran, M.
Girard, C.
Pallure, V
Perrot, J-L
Bastien, M.
Mahe, E.
Beauchet, A.
[J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (02): : 106 - 114
[10] Methotrexate in psoriasis under real-world conditions: long-term efficacy and tolerability
West, J.
Ogston, S.
Palmer, C.
Fleming, C.
Dawe, R.
Kumar, V.
Waterston, S.
Foerster, J.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (06) : 1407 - 1410

← 1 →